Knockdown of plexin-B1 in ovarian cancer-derived cells results in inhibition of AKT phosphorylation, re-arrangement of the actin cytoskeleton, and inhibition of tumor cell migration and invasion (Table 1) [59]. Here, PLXNB1 is linked to ovarian cancer.